Stereotactic ablative radiotherapy with targeted MRI-defined gross tumor dose escalation for prostate cancer: dosimetric feasibility and interfraction robustness

ConclusionSelective high-precision (i.e., mpMRI-defined targets, daily volumetric image guidance, intraprostatic fiducials) SBRT with GTV dose escalation seems feasible, without incremental dose to OAR. Prospective studies to determine its clinical benefit are warranted.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research